Petrovax announces positive results from long-CoV-III-21 trial of Longidaza for long-term pulmonary sequelae of COVID-19
New hope for long-COVID patients: Longidaza boosts exercise tolerance and improves pulmonary function.
Drug Manufacturers
ADCs breach barriers to become mainstream cancer treatment
Novo Holdings’ acquisition of Catalent gains EC approval
Eli Lilly to invest $3bn in Wisconsin facility expansion
From Cobenfy to Emraclidine: the muscarinic path to safer antipsychotics
CPI’s Medicines Manufacturing Innovation Centre takes delivery of PACE Just in Time (JIT) Clinical Trials Drug Dispensing System
Samsung Biologics inks $668m manufacturing deal with European pharma
Injectables manufacturing ushers in a new era of accessibility
